Crossref
Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival
Journal of Pharmacy and Pharmacology Research · 2026
DOI: 10.26502/fjppr.0129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2026. Verfasst von Jan Hysing und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hysing, J., Thalamus, J., Gibbs, C., Holla, Ø. L., Jaioun, K., Hoff, G., & Haugaa, K. H. (2026). Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0129
Vancouver
Hysing J, Thalamus J, Gibbs C, Holla ØL, Jaioun K, Hoff G, et al. Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival. Journal of Pharmacy and Pharmacology Research. 2026. doi:10.26502/fjppr.0129
BibTeX
@article{Hysing2026,
author = {Hysing, Jan and Thalamus, Jacob and Gibbs, Charlotte and Holla, Øystein Lunde and Jaioun, Keson and Hoff, Geir and Haugaa, Kristina H},
title = {Beta-Blocker Use in Acquired Long QT Syndrome is Associated with Better Survival},
journal = {Journal of Pharmacy and Pharmacology Research},
year = {2026},
doi = {10.26502/fjppr.0129}
}
EUVIMED